V. Sparacino

发表

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

B. Dimitrov, N. Perico, G. Remuzzi, 2004, The Lancet.

Building Kidney Exchange Programmes in Europe—An Overview of Exchange Practice and Activities

Rachel J. Johnson, F. Spieksma, C. Jacquelinet, 2019, Transplantation.

Performance of Different Prediction Equations for Estimating Renal Function in Kidney Transplantation

N. Perico, G. Remuzzi, M. Salvadori, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

G. Remuzzi, B. Ene-Iordache, M. Salvadori, 2007, Journal of the American Society of Nephrology : JASN.

Chronic allograft nephropathy – a clinical syndrome: early detection and the potential role of proliferation signal inhibitors

J. D. de Fijter, J. Chapman, J. Pascual, 2009, Clinical transplantation.

Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.

G. Cerasola, M. Soresi, G. Montalto, 2007, Archives of medical research.

Platelet, Erythrocyte and Plasma Magnesium Levels in Renal Transplant Recipients During Cyclosporin or Azathioprine Treatment

A. Allegra, M. Buemi, R. D’angelo, 1997 .

Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

V. Sparacino, M. Averna, C. Barbagallo, 1993, Nephron.

Determinants of enhanced thromboxane biosynthesis in renal transplantation.

G. Davı̀, C. Barbagallo, S. Basili, 2001, Kidney international.

Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.

P. Rigotti, G. Segoloni, F. Citterio, 2005, Transplantation proceedings.

Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin‐related side‐effects

U. Kunzendorf, R. Margreiter, U. Heemann, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Kidney transplantation from donors with viral B and C hepatitis.

V. Sparacino, M. Veroux, P. Veroux, 2006, Transplantation proceedings.

Pancreatic enzymes in chronic renal failure and transplant patients

M. Soresi, A. Carroccio, G. Montalto, 1992, International journal of pancreatology : official journal of the International Association of Pancreatology.

[Effects of cyclosporin A on various indices of cholestasis in kidney transplant recipients].

M. Soresi, A. Carroccio, G. Montalto, 1995, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

D. Serraino, P. Piselli, F. Schena, 2013, European journal of cancer.

Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.

J. Albanell, J. D. de Fijter, J. Chapman, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.

B. Dimitrov, N. Perico, G. Remuzzi, 2005, Transplantation proceedings.

Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.

A. Allegra, M. Buemi, A. Corsonello, 1998, Magnesium research.

Everolimus With Very Low-Exposure Cyclosporine A in De Novo Kidney Transplantation: A Multicenter, Randomized, Controlled Trial

M. Salvadori, C. Ponticelli, S. Federico, 2009, Transplantation.

[Italian Registry Dialysis and Transplant 2011-2013].

F. Conte, M. Postorino, G. Reboldi, 2016, Giornale Italiano di Nefrologia.

Building Kidney Exchange Programmes in Europe—An Overview of Exchange Practice and Activities

David Manlove, Bart Smeulders, Katarína Cechlárová, 2019, Transplantation.

CAROTID ATHEROSCLEROSIS IN RENAL TRANSPLANT RECIPIENTS

C. Barbagallo, S. Novo, G. Licata, 2000 .

Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.

C. Barbagallo, S. Novo, G. Licata, 1999, Transplantation.

Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine.

C. Ponticelli, B. Cesana, F. Citterio, 2003, Transplantation proceedings.

Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.

R. Margreiter, E. Pohanka, V. Sparacino, 2005, Transplantation proceedings.

Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report.

V. Sparacino, S. Calabrese, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.

M. Salvadori, C. Ponticelli, F. Schena, 2005, Transplantation proceedings.

Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.

E. Cibelli, F. Venuta, S. Vesconi, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.